Update for the 2018/19 Invitation to Tender - 12 December 2018

Tender Closed

There is a change to the 2018/19 Invitation to Tender that was issued on 1 November 2018.  These amendments have been uploaded to the webpage and e-portal as relevant.

There is a change to the 2018/19 Invitation to Tender that was issued on 1 November 2018.  These amendments have been uploaded to the webpage and e-portal as relevant.

Amendment to line items

Line items have been amended for the following products (change in italics):

  • Busulfan – tab 2 mg: tender extended to include listing in community and hospital settings
  • Mercaptopurine – tab 50 mg: tender extended to include listing in community and hospital settings
  • Methotrexate – inj 25 mg per ml, 2 ml: tender extended to include listing in community and hospital settings
  • Methotrexate – inj 25 mg per ml, 20 ml: tender extended to include listing in community and hospital settings
  • Vincristine sulphate – inj 1 mg per ml, 1-2 ml: tender extended to include listing in community and hospital settings

More information

If you have any queries regarding the tender, please contact the tender analysts at tender@pharmac.govt.nz